After a breast cancer diagnosis, your doctor sometimes rattles off words like "estrogen, progesterone, HER2" while looking at the results of the tumor tests. The first time you hear them, they sound like an alien language. Among these, when all three come back negative, it is called triple-negative breast cancer. In English it is called triple negative, which, literally, means that all three markers are "absent." The name is a bit blunt, but in fact this one line holds almost everything about the character of this cancer.
Why do these three matter? Usually, breast cancer treatment takes the approach of finding out what the tumor "feeds on to grow" and then cutting off that food. If the hormone receptors are positive, a drug that blocks female hormones is used, and if HER2 is positive, a targeted drug aimed at that protein is used. Both are quite effective weapons. But in triple-negative cancer, all three of these keyholes are blocked, so neither the hormone drug nor the HER2 targeted drug fits as a key. That is why, for a long time, chemotherapy — what people commonly call anticancer injections — was almost the only option. This is where the word "tricky" comes from, because there were relatively few precise weapons available.
On top of that, triple-negative cancer is found at a relatively young age fairly often, and the tumor tends to grow quickly, so the progression can feel urgent at times. It also appears more frequently in people who carry a particular gene (BRCA) mutation. Its share among all breast cancers is not that high, but because its character is so distinct, it tends to live up to its name. One thing not to misunderstand, though: "tricky" absolutely does not mean "untreatable." It means the well-trodden path is narrow, not that it is a dead end.
In fact, the mood has changed quite a bit over the past few years. Treatments that add immunotherapy to chemotherapy to help our bodys immune cells attack the cancer directly, new targeted drugs used for people with specific gene mutations, and antibody-drug conjugates that deliver drugs precisely to the tumor have appeared one after another. Whereas you used to get by on a single anticancer injection, now options are stacking up layer by layer on top of that. Many people find, once they actually begin treatment, that there are more branches in the path than they expected.
So if you have received this diagnosis, I hope you will not get swept up in internet searches and become frightened from the start. Depending on the size of the tumor, the state of the lymph nodes, and the results of genetic testing, the treatment picture is drawn quite differently from person to person. The course of the person next door is not your course. Note down your questions and ask them one by one at your appointment, and if you are worried about whether it is hereditary, getting genetic counseling can also help you sort out your thoughts.
This article is only a summary put together to help you understand triple-negative breast cancer, so please be sure to decide on diagnosis and treatment by discussing directly with your own medical team.